119 related articles for article (PubMed ID: 11312674)
1. Polymeric prodrug for release of an antitumoral agent by specific enzymes.
Cavallaro G; Pitarresi G; Licciardi M; Giammona G
Bioconjug Chem; 2001; 12(2):143-51. PubMed ID: 11312674
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of macromolecule-bound derivatives of a peptidyl-1-beta-D-arabinofuranosylcytosine prodrug.
Balajthy Z
Drug Metab Lett; 2008 Apr; 2(2):83-9. PubMed ID: 19356076
[TBL] [Abstract][Full Text] [Related]
3. A preclinical evaluation of cytarabine prodrug nanofibers assembled from cytarabine-lauric acid conjugate toward solid tumors.
Liu R; Jiang Y; Hu X; Wu J; Jiang W; Jin G; Luan Y
Int J Pharm; 2018 Dec; 552(1-2):111-118. PubMed ID: 30268848
[TBL] [Abstract][Full Text] [Related]
4. Folate-mediated targeting of polymeric conjugates of gemcitabine.
Cavallaro G; Licciardi M; Salmaso S; Caliceti P; Gaetano G
Int J Pharm; 2006 Jan; 307(2):258-69. PubMed ID: 16298091
[TBL] [Abstract][Full Text] [Related]
5. Polyaspartamide-doxorubicin conjugate as potential prodrug for anticancer therapy.
Di Meo C; Cilurzo F; Licciardi M; Scialabba C; Sabia R; Paolino D; Capitani D; Fresta M; Giammona G; Villani C; Matricardi P
Pharm Res; 2015 May; 32(5):1557-69. PubMed ID: 25366547
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and functional evaluation of a peptide derivative of 1-beta-D-arabinofuranosylcytosine.
Balajthy Z; Aradi J; Kiss IT; Elödi P
J Med Chem; 1992 Sep; 35(18):3344-9. PubMed ID: 1527783
[TBL] [Abstract][Full Text] [Related]
7. Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard.
Chakravarty PK; Carl PL; Weber MJ; Katzenellenbogen JA
J Med Chem; 1983 May; 26(5):633-8. PubMed ID: 6221099
[TBL] [Abstract][Full Text] [Related]
8. Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies.
Giammona G; Cavallaro G; Fontana G; Pitarresi G; Carlisi B
J Control Release; 1998 Aug; 54(3):321-31. PubMed ID: 9766252
[TBL] [Abstract][Full Text] [Related]
9. Macromolecular prodrugs based on synthetic polyaminoacids: drug delivery and drug targeting in antitumor therapy.
Cavallaro G; Pitarresi G; Giammona G
Curr Top Med Chem; 2011; 11(18):2382-9. PubMed ID: 21671863
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug.
de Groot FM; Broxterman HJ; Adams HP; van Vliet A; Tesser GI; Elderkamp YW; Schraa AJ; Kok RJ; Molema G; Pinedo HM; Scheeren HW
Mol Cancer Ther; 2002 Sep; 1(11):901-11. PubMed ID: 12481411
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated "prodrugs" for cancer chemotherapy.
Carl PL; Chakravarty PK; Katzenellenbogen JA; Weber MJ
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2224-8. PubMed ID: 6246527
[TBL] [Abstract][Full Text] [Related]
12. Cytarabine release from alpha, beta-poly (N-hydroxyethyl)-DL-aspartamide matrices cross-linked through gamma-radiation.
Spadaro G; Dispenza C; Giammona G; Pitarresi G; Cavallaro G
Biomaterials; 1996 May; 17(10):953-8. PubMed ID: 8736728
[TBL] [Abstract][Full Text] [Related]
13. Plasmin-activated prodrugs for cancer chemotherapy. 2. Synthesis and biological activity of peptidyl derivatives of doxorubicin.
Chakravarty PK; Carl PL; Weber MJ; Katzenellenbogen JA
J Med Chem; 1983 May; 26(5):638-44. PubMed ID: 6302253
[TBL] [Abstract][Full Text] [Related]
14. Macromolecular prodrugs. XII. Primaquine conjugates: synthesis and preliminary antimalarial evaluation.
Rajić Z; Kos G; Zorc B; Singh PP; Singh S
Acta Pharm; 2009 Mar; 59(1):107-15. PubMed ID: 19304563
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
de Groot FM; van Berkom LW; Scheeren HW
J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and cytotoxicity evaluation of self-assembled nanoparticles of diosgenin-cytarabine conjugate.
Liao AM; Zhang Y; Hou Y; Huang JH; Hui M; Lee KK; Lee KY; Chun C
Food Chem Toxicol; 2021 May; 151():112101. PubMed ID: 33684518
[TBL] [Abstract][Full Text] [Related]
17. Anticancer drug delivery systems: N4-acyl poly(ethyleneglycol) prodrugs of ara-C. I. Efficacy in solid tumors.
Choe YH; Conover CD; Wu D; Royzen M; Greenwald RB
J Control Release; 2002 Feb; 79(1-3):41-53. PubMed ID: 11853917
[TBL] [Abstract][Full Text] [Related]
18. Preparation and antitumor activity of a polymeric derivative of methotrexate.
Zhou G; Cheng X; Wu S; Jiang X; Shi X; Chen J; Zhang J; Zhao J
Am J Med Sci; 2012 Oct; 344(4):294-9. PubMed ID: 22885620
[TBL] [Abstract][Full Text] [Related]
19. Controllable selective synthesis of a polymerizable prodrug of cytarabine by enzymatic and chemical methods.
Wang N; Chen ZC; Lu DS; Lin XF
Bioorg Med Chem Lett; 2005 Sep; 15(18):4064-7. PubMed ID: 16005210
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of fatty acyl ester derivatives of cytarabine as anti-leukemia agents.
Chhikara BS; Mandal D; Parang K
Eur J Med Chem; 2010 Oct; 45(10):4601-8. PubMed ID: 20692740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
